DESIGN. ANALYZE. ADVANCE.
Live / Allowed — Approved for publication (as of 30 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99318283
- Mark type
- Stylized text
- Filed
- 04 Aug 2025
- Attorney of record
- Marc P. Misthal
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of clinical trial results, namely, reporting and presentation of clinical trial results; Providing consulting services in the field of regulatory submission management to medical, biopharmaceutical and biotechnology companies to assist them with the submission of clinical trial results for applications for new pharmaceuticals and medical devices with governmental regulatory bodies; Regulatory submission management, namely, responding to inquiries regarding clinical trials from governmental regulatory bodies; Customer services, namely, responding to participant inquiries for others regarding clinical trials
- Class 042 — Scientific and technological services: Consulting services for pharmaceutical, medical device, biotechnology, and medical research industries; consulting services in the field of expert review of proposed clinical trial design; software as a service (SaaS) featuring software for statistical analysis and simulation tools for clinical trial design, analysis, and optimization; providing an online non-downloadable computer software platform for running in vivo studies; providing an online non-downloadable computer software platform for running in silico studies; data modeling and statistical consulting services for the pharmaceutical, medical device, biotechnology, and medical research industries; design, development and implementation of software for in vivo simulations; design, development and implementation of software for in silico simulations
- Class 045 — Legal and security services: Representation of clients in biomedical and pharmaceutical regulatory proceedings
Owner
- BIOMEDICAL STATISTICAL CONSULTING IP LLC, PHILADELPHIA, PA, US
Prosecution history
- 30 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 30 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 30 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 20 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Mar 2026 — NON-FINAL ACTION E-MAILED
- 20 Mar 2026 — NON-FINAL ACTION WRITTEN
- 17 Dec 2025 — ASSIGNED TO EXAMINER
- 11 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 04 Aug 2025 — NEW APPLICATION ENTERED